Find your path to Andrew
242 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.
Ben PerryunlockedAndrew: together at UCB (2006–2008)
×4Andrew: together at GSK
×5Andrew: together at University of Hertfordshire
Andrew: together at UCB
About
Andrew Baxendale is COO at NK:IO Ltd. He has over 30 years of experience in drug discovery and development across the pharmaceutical, biotech, and service sectors, with work spanning multiple therapeutic areas and development phases. His background includes leadership and board roles, seed fund raising, company creation, licensing transactions, and the negotiation of development alliances.
Executive at NKIO Seed
Intro paths
→
In turn, Andrew can intro founders to NKIO Seed's investors below.
NKIO Seed's investors · 3
Co-founders at NKIO Seed
HB
Hugh BradyCo-founder
MJ
Matthew J. FuchterCo-founder
Experience
- NK:IO LtdCOOcurrent2021 — presentUK
- Baxendale Consulting LtdBiotech Leader and Consultantcurrent2019 — presentCambridge, United Kingdom
- Cycle PharmaceuticalsBusiness Unit Head, PARP Inhibitors2017 — 2019Cambridge, United Kingdom
- BAXENDALE CONSULTING LIMITEDLife Science Consultant2017
- TakedaGlobal Programme Leader2014 — 2017
- Aptiv SolutionsSenior Development Director2011 — 2014Stevenage, United Kingdom
- Fulcrum PharmaDevelopment Director2008 — 2011
- UCBGlobal Project Leader2006 — 2008
- Daiichi SankyoProject Leader2005 — 2006
- GSKClinical Manager1995 — 2005
- GSKResearch Scientist1989 — 1995
Skills & more
Fundraising1Development Strategy1Start-up Ventures1Clinical Research12Biotechnology9Pharmacology6Project Management6Oncology5Biopharmaceuticals4Drug Development4GCP4Life Sciences4
+11 more
Drug DiscoveryRegulatory AffairsTherapeutic AreasResearch and Development (R&D)Good Clinical Practice (GCP)Business DevelopmentDue DiligenceConsultingLeadershipStrategyManagementFrom Andrew's professional profile.
Frequently asked questions
- Who is Andrew Baxendale?
- Andrew Baxendale is COO at NK:IO Ltd. He has over 30 years of experience in drug discovery and development across the pharmaceutical, biotech, and service sectors, with work spanning multiple therapeutic areas and development phases. His background includes leadership and board roles, seed fund raising, company creation, licensing transactions, and the negotiation of development alliances.
- Where did Andrew Baxendale go to school?
- Andrew Baxendale studied at University of Hertfordshire (PhD, Pharmacology/ Physiology); Nottingham Trent University (BSc, Applied Biology).
Same school
Also attended University of Hertfordshire62
Roger FontAnalyst at Inveready Technology Investment GroupYogesh KamraHead of Lab Operations (UK site) at Illumina VenturesLucía SáenzInvestment & Community Intern at Kibo VenturesAlpesh AnandSalesforce Consultant & Administrator at EMV CapitalElaine HegartyChief of Staff at IQ CapitalMarco BrunsFinance & Operations Manager at Redstone
+ 56 more
Also attended Nottingham Trent University45
Hristo BorisovCo-founder & CEO of PayhawkVasso FantousiLegal Counsel at RTP GlobalNicki MughalChief of Staff & People Operations Officer at White Star CapitalFiona RooneyGeneral Counsel at InHealth VenturesCharlie SmithFund Coordinator at Mercia VenturesHannah WilliamsonSenior Investment Manager at Edge VC
+ 39 more
Shared employers
Also worked at Takeda77
Rebecca RedfieldSenior Associate at .406 VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersDai HataAssociate at AN Venture PartnersJulie KimRepresentative Director – President and CEO at Takeda VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAsuka MiyabashiraPresident, Japan Pharma Business Unit at Takeda Ventures
+ 71 more
Also worked at Aptiv Solutions1
Also worked at UCB34
Ben PerryInvestor at MedicxiStephen RapeckiInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite Capital
+ 28 more
Also worked at Daiichi Sankyo12
Mary PattonScientific Advisory Board at InnoCom Bio EquitiesScott GottliebPartner at New Enterprise Associates (NEA)Henri CournandCFO at SemperVirens Venture CapitalVickie LaurentRegulatory Advisor at 2Flo VenturesSandra ClarkeAdvisor at Allumia VenturesRecai Serdar GemiciFounder at Albert Health
+ 6 more